Significant worldwide disparities in availability and timeliness of new cancer drugs
Despite considerable progress in the discovery and development of new cancer drugs, there are significant…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Despite considerable progress in the discovery and development of new cancer drugs, there are significant…
A growing reliance on industry-sponsored cancer clinical trials in the United States is a reason…
Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing…
All cells within the same cancer are not the same. They all have genetic errors…
A study led by researchers of the Institute of Biomedicine of the University of Barcelona…
Prostate cancer (PCa) is a common cancer in men, requiring accurate diagnosis and monitoring of…
October 16th 2024 sees the launch of Metastatic Breast Cancer Action Australia (MBC Action Australia),…
The Australian-led TRANSFORM trial has found that stereotactic radiation therapy for metastatic prostate cancer can…
Welcome to Episode 10 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for another informative, educational and fun episode.
Research from the University of California, Irvine, USA, has revealed how disruption of the circadian…